IKT
Inhibikase Therapeutics Inc
2.00$
+3.6%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | -147.3% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | +2,538.7% | -85.2% | +130.3% | |
| – | -3.0% | +113.6% | +123.7% | -60.1% | +167.0% | -70.1% | +9.2% | +1,527.6% | +88.1% | |
| – | +10.8% | +294.7% | +59.9% | +1.0% | +3.2% | – | – | – | – | |
| – | -116.9% | – | +7.6% | -128.5% | – | – | +37.1% | -12.7% | -72.7% | |
| – | – | – | – | – | – | +24,325,400.0% | -94.1% | -100.0% | – | |
| – | +0.0% | +0.0% | – | – | – | – | – | -417.5% | – | |
| – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | |
| – | – | -120.1% | -13.3% | – | -115.6% | +485.2% | -100.0% | – | – | |
| – | – | -435.2% | -94.8% | – | +172.8% | -100.5% | – | +1,131.1% | +4.8% | |
| – | – | +7,739.5% | -199.5% | – | +92.3% | -225.2% | – | +2,294.3% | +74.8% | |
| – | – | – | -147.3% | – | – | – | – | – | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.